| Name | Title | Contact Details |
|---|
Atlanta Design Group (ADG) is a Full-Service Interior Design Company made up of a group of specialized brands offering numerous products and services supporting the interior design and design-build trades. ADG was organized to meet the needs of the design profession in an ever-changing global market. By diversifying our products and services and providing our clients with a customer experience designed to span the lifetime of the project, ADG is redefining how the design industry conducts business. Atlanta Design Group covers all the bases to include interior design; specialized marketing; furniture and accessories; outdoor living; kitchen & bath; specialty construction products, fine art and framing, lighting solutions and installation and logistics services making your job more streamlined than ever. We are confident that forming a business relationship with our company is the absolute best move you can make towards growing and advancing your business to the next level. Working together, Atlanta Design Group is a single, turnkey source working for you. One Company, One Source, One Solution The Power of One
Machines and Systems for Solid Wood Processing You can concentrate on your business, let us do everything else! WEINIG is not only the leading manufacturer for the solid wood processing industry, we lead this industry in technology and ideas! WEINIG offers comprehensive services and system solutions – all the way to complete turnkey production plants – making WEINIG the all-around ideal partner where the focus is always on flexible, profitable production.
During its 20-plus-year history, MVB Bank has grown from a community bank with 35 employees to a forward-thinking, NASDAQ-listed, Russell 2000® company with more than 400 Team Members living in more than 25 different states. Headquartered in Fairmont, West Virginia, MVB Bank and the Banks subsidiaries, the MVB Community Development Corp., Chartwell Compliance, Paladin and Trabian, provide financial services to individuals and corporate clients in the Mid-Atlantic region and beyond. MVB Financial Corp., the holding company of MVB Bank, is publicly traded on The Nasdaq Capital Market under the ticker "MVBF."
iwis is one of the worlds leading suppliers of chain system solutions for the automotive industry as well as for drive and conveyor purposes in numerous industries. What began with a bicycle chain quickly grew into a successful, likeable family business - and ultimately into a global technology leader in the field of high-quality chain system solutions and engineering service provider. By expanding our product range with high-precision stamped and bent parts as well as precision plastic parts, multi-component and composite parts, we continue to lead the automotive sector towards the future in terms of mobility and regenerative energy generation. Our product brands JWIS, ELITE,FLEXON as well as EUROCHAIN, ECOPLUS and MEGALIFE offer suitable solutions for every quality requirement. Our team counts more than 3,000 employees working at numerous international locations: dedicated professionals working in the 3 divisions Mobility Systems, Drive Systems, and Mechatronics on development and optimization as well as in manufacturing and quality testing. For solutions that really move the world. Our goal is perfection - no more, no less. The expertise of our engineers lies in identifying trends, developing new material and manufacturing technologies, and customized solutions. Our research and development competence center stands for innovation and partnership. This makes us a strong and reliable partner. Imprint: https://www.iwis.com/en-gb/imprint
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.